Literature DB >> 17623040

Mortality, oxidative stress and tau accumulation during ageing in parkin null mice.

Jose A Rodríguez-Navarro1, M José Casarejos, Jaime Menéndez, Rosa M Solano, Izaskun Rodal, Ana Gómez, Justo García de Yébenes, Maria A Mena.   

Abstract

Young parkin null (pk-/-) mice have subtle abnormalities of behaviour, dopamine (DA) neurotransmission and free radical production, but no massive loss of DA neurons. We investigated whether these findings are maintained while ageing. Pk-/- mice have reduced life span and age-related reduced exploratory behaviour, abnormal walking and posture, and behaviours similar to those of early Parkinson's disease (PD), reduced number of nigrostriatal DA neurons and proapoptotic shifts in the survival/death proteins in midbrain and striatum. Contrary to young pk-/- animals 24-month-old pk-/- mice do not have compensatory elevation of GSH in striatum, glutathione reductase (GR) and glutathione peroxidase (GPx) activities are increased and catalase unchanged. Aged pk-/- mice accumulate high levels of tau and fail to up-regulate CHIP and HSP70. Our results suggest that aged pk-/- mice lack of the compensatory mechanisms that maintain a relatively normal DA function in early adulthood. This study could help to explain the effects of ageing in patients with genetic risks for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623040     DOI: 10.1111/j.1471-4159.2007.04762.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Altered hippocampal synaptic physiology in aged parkin-deficient mice.

Authors:  Jesse E Hanson; Adrienne L Orr; Daniel V Madison
Journal:  Neuromolecular Med       Date:  2010-03-16       Impact factor: 3.843

Review 2.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

3.  Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

Authors:  Meghan R Hennis; Marian A Marvin; Charles M Taylor; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2013-09-26       Impact factor: 5.996

Review 4.  Drug-induced parkinsonism in the elderly: incidence, management and prevention.

Authors:  José Luis López-Sendón; María Angeles Mena; Justo García de Yébenes
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 5.  Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy.

Authors:  Lingling Jiao; Xixun Du; Yong Li; Qian Jiao; Hong Jiang
Journal:  Mol Biol Rep       Date:  2022-07-06       Impact factor: 2.316

Review 6.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 7.  The multiple mechanisms of amyloid deposition: the role of parkin.

Authors:  Maria A Mena; José A Rodríguez-Navarro; Justo García de Yébenes
Journal:  Prion       Date:  2009-01-09       Impact factor: 3.931

8.  Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions.

Authors:  Ana P Fernández; Julia Serrano; Lino Tessarollo; Frank Cuttitta; Alfredo Martínez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

Review 9.  Parkin in Parkinson's Disease and Cancer: a Double-Edged Sword.

Authors:  Khushnuma Wahabi; Ahmad Perwez; Moshahid A Rizvi
Journal:  Mol Neurobiol       Date:  2018-01-18       Impact factor: 5.590

Review 10.  Parkinson's disease mouse models in translational research.

Authors:  Paul M A Antony; Nico J Diederich; Rudi Balling
Journal:  Mamm Genome       Date:  2011-05-11       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.